nodes	percent_of_prediction	percent_of_DWPC	metapath
Sucralfate—FGA—hindbrain—amyotrophic lateral sclerosis	0.0373	0.111	CbGeAlD
Sucralfate—FGB—embryo—amyotrophic lateral sclerosis	0.0273	0.0813	CbGeAlD
Sucralfate—EGF—hindbrain—amyotrophic lateral sclerosis	0.0272	0.0813	CbGeAlD
Sucralfate—FGA—embryo—amyotrophic lateral sclerosis	0.0233	0.0696	CbGeAlD
Sucralfate—FGA—brainstem—amyotrophic lateral sclerosis	0.0214	0.0638	CbGeAlD
Sucralfate—PGA5—nervous system—amyotrophic lateral sclerosis	0.0193	0.0575	CbGeAlD
Sucralfate—PGA5—central nervous system—amyotrophic lateral sclerosis	0.0185	0.0553	CbGeAlD
Sucralfate—EGF—embryo—amyotrophic lateral sclerosis	0.017	0.0508	CbGeAlD
Sucralfate—EGF—brainstem—amyotrophic lateral sclerosis	0.0156	0.0466	CbGeAlD
Sucralfate—PGA5—brain—amyotrophic lateral sclerosis	0.0147	0.0439	CbGeAlD
Sucralfate—FGA—nervous system—amyotrophic lateral sclerosis	0.0112	0.0334	CbGeAlD
Sucralfate—FGA—central nervous system—amyotrophic lateral sclerosis	0.0108	0.0322	CbGeAlD
Sucralfate—FGA—cerebellum—amyotrophic lateral sclerosis	0.0105	0.0315	CbGeAlD
Sucralfate—EGF—spinal cord—amyotrophic lateral sclerosis	0.00971	0.029	CbGeAlD
Sucralfate—FGF2—medulla oblongata—amyotrophic lateral sclerosis	0.00961	0.0287	CbGeAlD
Sucralfate—FGF2—spinal cord—amyotrophic lateral sclerosis	0.00857	0.0256	CbGeAlD
Sucralfate—FGA—brain—amyotrophic lateral sclerosis	0.00856	0.0255	CbGeAlD
Sucralfate—EGF—nervous system—amyotrophic lateral sclerosis	0.00818	0.0244	CbGeAlD
Sucralfate—EGF—central nervous system—amyotrophic lateral sclerosis	0.00788	0.0235	CbGeAlD
Sucralfate—EGF—cerebellum—amyotrophic lateral sclerosis	0.0077	0.023	CbGeAlD
Sucralfate—FGF2—cerebellum—amyotrophic lateral sclerosis	0.00679	0.0203	CbGeAlD
Sucralfate—EGF—brain—amyotrophic lateral sclerosis	0.00625	0.0187	CbGeAlD
Sucralfate—FGF2—brain—amyotrophic lateral sclerosis	0.00552	0.0165	CbGeAlD
Sucralfate—ALB—brain—amyotrophic lateral sclerosis	0.00216	0.00645	CbGeAlD
Sucralfate—FGB—Extracellular matrix organization—CASP3—amyotrophic lateral sclerosis	0.000636	0.000956	CbGpPWpGaD
Sucralfate—EGF—Disease—CHMP2B—amyotrophic lateral sclerosis	0.000631	0.000949	CbGpPWpGaD
Sucralfate—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—amyotrophic lateral sclerosis	0.000626	0.000941	CbGpPWpGaD
Sucralfate—FGA—Extracellular matrix organization—CASP3—amyotrophic lateral sclerosis	0.000623	0.000937	CbGpPWpGaD
Sucralfate—FGG—Extracellular matrix organization—CASP3—amyotrophic lateral sclerosis	0.000623	0.000937	CbGpPWpGaD
Sucralfate—FGB—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	0.000622	0.000935	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000615	0.000925	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—SQSTM1—amyotrophic lateral sclerosis	0.000613	0.000923	CbGpPWpGaD
Sucralfate—FGF2—NGF signalling via TRKA from the plasma membrane—ERBB4—amyotrophic lateral sclerosis	0.00061	0.000917	CbGpPWpGaD
Sucralfate—FGA—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	0.000609	0.000916	CbGpPWpGaD
Sucralfate—FGG—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	0.000609	0.000916	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.000609	0.000916	CbGpPWpGaD
Sucralfate—EGF—Signaling by SCF-KIT—MMP9—amyotrophic lateral sclerosis	0.000607	0.000912	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000602	0.000906	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000602	0.000906	CbGpPWpGaD
Sucralfate—FGB—Extracellular matrix organization—MMP9—amyotrophic lateral sclerosis	0.000601	0.000904	CbGpPWpGaD
Sucralfate—FGA—Extracellular matrix organization—MMP9—amyotrophic lateral sclerosis	0.000589	0.000885	CbGpPWpGaD
Sucralfate—FGG—Extracellular matrix organization—MMP9—amyotrophic lateral sclerosis	0.000589	0.000885	CbGpPWpGaD
Sucralfate—FGA—Disease—CST3—amyotrophic lateral sclerosis	0.000585	0.00088	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000583	0.000877	CbGpPWpGaD
Sucralfate—EGF—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	0.000582	0.000876	CbGpPWpGaD
Sucralfate—ALB—Folate Metabolism—SOD1—amyotrophic lateral sclerosis	0.000579	0.000871	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—ATF1—amyotrophic lateral sclerosis	0.000575	0.000865	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000571	0.000859	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000571	0.000859	CbGpPWpGaD
Sucralfate—EGF—Disease—PLB1—amyotrophic lateral sclerosis	0.000571	0.000859	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000564	0.000849	CbGpPWpGaD
Sucralfate—EGF—MAPK Signaling Pathway—CASP3—amyotrophic lateral sclerosis	0.000558	0.000839	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000553	0.000832	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000553	0.000832	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—CASP9—amyotrophic lateral sclerosis	0.000548	0.000824	CbGpPWpGaD
Sucralfate—EGF—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	0.000542	0.000816	CbGpPWpGaD
Sucralfate—FGF2—Immune System—KIFAP3—amyotrophic lateral sclerosis	0.000541	0.000814	CbGpPWpGaD
Sucralfate—ALB—Lipid and lipoprotein metabolism—APOE—amyotrophic lateral sclerosis	0.000534	0.000803	CbGpPWpGaD
Sucralfate—FGF2—Disease—VTA1—amyotrophic lateral sclerosis	0.000527	0.000793	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—DCTN1—amyotrophic lateral sclerosis	0.000526	0.000791	CbGpPWpGaD
Sucralfate—ALB—Vitamin B12 Metabolism—APOE—amyotrophic lateral sclerosis	0.000525	0.00079	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—ATF1—amyotrophic lateral sclerosis	0.000518	0.00078	CbGpPWpGaD
Sucralfate—EGF—Disease—VCP—amyotrophic lateral sclerosis	0.000509	0.000765	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—TUBA4A—amyotrophic lateral sclerosis	0.000506	0.000761	CbGpPWpGaD
Sucralfate—EGF—Immune System—DCTN1—amyotrophic lateral sclerosis	0.000504	0.000758	CbGpPWpGaD
Sucralfate—EGF—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.000504	0.000757	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000501	0.000754	CbGpPWpGaD
Sucralfate—ALB—Platelet degranulation—SOD1—amyotrophic lateral sclerosis	0.000497	0.000747	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000496	0.000745	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—CASP9—amyotrophic lateral sclerosis	0.000494	0.000743	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—SOD1—amyotrophic lateral sclerosis	0.000492	0.00074	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000491	0.000738	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000491	0.000738	CbGpPWpGaD
Sucralfate—FGB—Hemostasis—IGF1—amyotrophic lateral sclerosis	0.000491	0.000738	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000485	0.00073	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000485	0.00073	CbGpPWpGaD
Sucralfate—FGA—Hemostasis—IGF1—amyotrophic lateral sclerosis	0.000481	0.000723	CbGpPWpGaD
Sucralfate—FGG—Hemostasis—IGF1—amyotrophic lateral sclerosis	0.000481	0.000723	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—CASP9—amyotrophic lateral sclerosis	0.000474	0.000713	CbGpPWpGaD
Sucralfate—ALB—Response to elevated platelet cytosolic Ca2+—SOD1—amyotrophic lateral sclerosis	0.000473	0.000712	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—ERBB4—amyotrophic lateral sclerosis	0.000469	0.000705	CbGpPWpGaD
Sucralfate—ALB—Selenium Micronutrient Network—SOD1—amyotrophic lateral sclerosis	0.00046	0.000692	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—PFN1—amyotrophic lateral sclerosis	0.000456	0.000685	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000452	0.00068	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	0.000441	0.000664	CbGpPWpGaD
Sucralfate—EGF—Focal Adhesion—VEGFA—amyotrophic lateral sclerosis	0.000429	0.000645	CbGpPWpGaD
Sucralfate—EGF—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.000427	0.000643	CbGpPWpGaD
Sucralfate—FGA—Disease—CASP9—amyotrophic lateral sclerosis	0.000425	0.00064	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—ERBB4—amyotrophic lateral sclerosis	0.000423	0.000636	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.000414	0.000623	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000414	0.000622	CbGpPWpGaD
Sucralfate—ALB—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.000413	0.000621	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—ERBB4—amyotrophic lateral sclerosis	0.000406	0.00061	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.0004	0.000601	CbGpPWpGaD
Sucralfate—FGF2—Disease—CHMP2B—amyotrophic lateral sclerosis	0.000399	0.000601	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000384	0.000578	CbGpPWpGaD
Sucralfate—FGF2—Signaling by SCF-KIT—MMP9—amyotrophic lateral sclerosis	0.000384	0.000577	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—CD40LG—amyotrophic lateral sclerosis	0.000382	0.000574	CbGpPWpGaD
Sucralfate—EGF—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	0.00038	0.000572	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—KIFAP3—amyotrophic lateral sclerosis	0.000376	0.000566	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000376	0.000565	CbGpPWpGaD
Sucralfate—EGF—Disease—CST3—amyotrophic lateral sclerosis	0.000365	0.000549	CbGpPWpGaD
Sucralfate—EGF—Signaling by NGF—CASP3—amyotrophic lateral sclerosis	0.000365	0.000548	CbGpPWpGaD
Sucralfate—FGA—Disease—ERBB4—amyotrophic lateral sclerosis	0.000364	0.000548	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000361	0.000544	CbGpPWpGaD
Sucralfate—FGF2—Disease—PLB1—amyotrophic lateral sclerosis	0.000361	0.000543	CbGpPWpGaD
Sucralfate—EGF—MAPK Signaling Pathway—TP53—amyotrophic lateral sclerosis	0.000358	0.000538	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000356	0.000536	CbGpPWpGaD
Sucralfate—ALB—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000351	0.000528	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—C3—amyotrophic lateral sclerosis	0.000351	0.000528	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000345	0.000519	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	0.000343	0.000516	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.00034	0.000512	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—C3—amyotrophic lateral sclerosis	0.000337	0.000507	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000334	0.000502	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000334	0.000502	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—ATF1—amyotrophic lateral sclerosis	0.000328	0.000493	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000326	0.00049	CbGpPWpGaD
Sucralfate—EGF—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.000323	0.000486	CbGpPWpGaD
Sucralfate—FGF2—Disease—VCP—amyotrophic lateral sclerosis	0.000322	0.000484	CbGpPWpGaD
Sucralfate—EGF—Immune System—SQSTM1—amyotrophic lateral sclerosis	0.000322	0.000484	CbGpPWpGaD
Sucralfate—FGB—Hemostasis—VEGFA—amyotrophic lateral sclerosis	0.000321	0.000482	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000319	0.00048	CbGpPWpGaD
Sucralfate—FGF2—Immune System—DCTN1—amyotrophic lateral sclerosis	0.000319	0.00048	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.000319	0.000479	CbGpPWpGaD
Sucralfate—FGA—Hemostasis—VEGFA—amyotrophic lateral sclerosis	0.000314	0.000472	CbGpPWpGaD
Sucralfate—FGG—Hemostasis—VEGFA—amyotrophic lateral sclerosis	0.000314	0.000472	CbGpPWpGaD
Sucralfate—ALB—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000313	0.000471	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000313	0.000471	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000313	0.000471	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—CASP9—amyotrophic lateral sclerosis	0.000312	0.00047	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000306	0.000461	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000304	0.000457	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000303	0.000456	CbGpPWpGaD
Sucralfate—ALB—Platelet degranulation—IGF1—amyotrophic lateral sclerosis	0.000303	0.000456	CbGpPWpGaD
Sucralfate—EGF—Immune System—ATF1—amyotrophic lateral sclerosis	0.000302	0.000454	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—IGF1—amyotrophic lateral sclerosis	0.0003	0.000451	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—CASP9—amyotrophic lateral sclerosis	0.0003	0.000451	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000298	0.000448	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000298	0.000448	CbGpPWpGaD
Sucralfate—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—amyotrophic lateral sclerosis	0.000289	0.000434	CbGpPWpGaD
Sucralfate—EGF—Immune System—CASP9—amyotrophic lateral sclerosis	0.000288	0.000433	CbGpPWpGaD
Sucralfate—FGA—Disease—APOE—amyotrophic lateral sclerosis	0.000282	0.000424	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.00027	0.000407	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—ERBB4—amyotrophic lateral sclerosis	0.000267	0.000402	CbGpPWpGaD
Sucralfate—EGF—Disease—CASP9—amyotrophic lateral sclerosis	0.000266	0.000399	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—TUBA4A—amyotrophic lateral sclerosis	0.000261	0.000392	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.00026	0.000392	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—ERBB4—amyotrophic lateral sclerosis	0.000257	0.000386	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000255	0.000384	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000255	0.000384	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000253	0.000381	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000248	0.000373	CbGpPWpGaD
Sucralfate—EGF—Immune System—ERBB4—amyotrophic lateral sclerosis	0.000246	0.00037	CbGpPWpGaD
Sucralfate—FGF2—Extracellular matrix organization—CASP3—amyotrophic lateral sclerosis	0.000246	0.00037	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000245	0.000368	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—RAB5A—amyotrophic lateral sclerosis	0.000243	0.000365	CbGpPWpGaD
Sucralfate—FGB—Hemostasis—TP53—amyotrophic lateral sclerosis	0.000242	0.000364	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—CD40LG—amyotrophic lateral sclerosis	0.000241	0.000363	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.00024	0.000361	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.00024	0.000361	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000238	0.000358	CbGpPWpGaD
Sucralfate—FGA—Hemostasis—TP53—amyotrophic lateral sclerosis	0.000237	0.000357	CbGpPWpGaD
Sucralfate—FGG—Hemostasis—TP53—amyotrophic lateral sclerosis	0.000237	0.000357	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—PFN1—amyotrophic lateral sclerosis	0.000235	0.000353	CbGpPWpGaD
Sucralfate—ALB—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	0.000233	0.00035	CbGpPWpGaD
Sucralfate—FGF2—Extracellular matrix organization—MMP9—amyotrophic lateral sclerosis	0.000232	0.00035	CbGpPWpGaD
Sucralfate—EGF—Immune System—CD40LG—amyotrophic lateral sclerosis	0.000231	0.000348	CbGpPWpGaD
Sucralfate—FGF2—Disease—CST3—amyotrophic lateral sclerosis	0.000231	0.000348	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—CASP3—amyotrophic lateral sclerosis	0.000231	0.000347	CbGpPWpGaD
Sucralfate—EGF—Disease—ERBB4—amyotrophic lateral sclerosis	0.000227	0.000342	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000225	0.000339	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—C3—amyotrophic lateral sclerosis	0.000222	0.000334	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—SOD1—amyotrophic lateral sclerosis	0.00022	0.000331	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000218	0.000328	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000216	0.000325	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—C3—amyotrophic lateral sclerosis	0.000213	0.000321	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000212	0.000319	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000212	0.000319	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00021	0.000316	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000208	0.000313	CbGpPWpGaD
Sucralfate—EGF—Immune System—C3—amyotrophic lateral sclerosis	0.000205	0.000308	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.000204	0.000307	CbGpPWpGaD
Sucralfate—FGF2—Immune System—SQSTM1—amyotrophic lateral sclerosis	0.000204	0.000306	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000201	0.000303	CbGpPWpGaD
Sucralfate—ALB—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000201	0.000303	CbGpPWpGaD
Sucralfate—ALB—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000201	0.000303	CbGpPWpGaD
Sucralfate—ALB—Platelet degranulation—VEGFA—amyotrophic lateral sclerosis	0.000198	0.000298	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—PLA2G4A—amyotrophic lateral sclerosis	0.000198	0.000297	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000197	0.000297	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000197	0.000297	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—VEGFA—amyotrophic lateral sclerosis	0.000196	0.000295	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000195	0.000294	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000194	0.000292	CbGpPWpGaD
Sucralfate—FGA—Disease—PTGS2—amyotrophic lateral sclerosis	0.000193	0.00029	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000192	0.000288	CbGpPWpGaD
Sucralfate—FGF2—Immune System—ATF1—amyotrophic lateral sclerosis	0.000191	0.000287	CbGpPWpGaD
Sucralfate—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—amyotrophic lateral sclerosis	0.000188	0.000283	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000188	0.000282	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000186	0.00028	CbGpPWpGaD
Sucralfate—ALB—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000184	0.000277	CbGpPWpGaD
Sucralfate—FGF2—Immune System—CASP9—amyotrophic lateral sclerosis	0.000182	0.000274	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000179	0.000268	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000179	0.000268	CbGpPWpGaD
Sucralfate—EGF—Disease—APOE—amyotrophic lateral sclerosis	0.000176	0.000264	CbGpPWpGaD
Sucralfate—ALB—Folate Metabolism—TP53—amyotrophic lateral sclerosis	0.000174	0.000262	CbGpPWpGaD
Sucralfate—ALB—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000171	0.000258	CbGpPWpGaD
Sucralfate—FGF2—Disease—CASP9—amyotrophic lateral sclerosis	0.000168	0.000253	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.000166	0.00025	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.000163	0.000245	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.000163	0.000245	CbGpPWpGaD
Sucralfate—ALB—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000161	0.000242	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000159	0.000239	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000159	0.000239	CbGpPWpGaD
Sucralfate—FGF2—Immune System—ERBB4—amyotrophic lateral sclerosis	0.000156	0.000234	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.00015	0.000225	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—TP53—amyotrophic lateral sclerosis	0.000148	0.000223	CbGpPWpGaD
Sucralfate—FGF2—Immune System—CD40LG—amyotrophic lateral sclerosis	0.000146	0.00022	CbGpPWpGaD
Sucralfate—ALB—Metabolism—DAO—amyotrophic lateral sclerosis	0.000146	0.000219	CbGpPWpGaD
Sucralfate—FGF2—Disease—ERBB4—amyotrophic lateral sclerosis	0.000144	0.000216	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—MMP9—amyotrophic lateral sclerosis	0.000141	0.000212	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	0.000134	0.000202	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000132	0.000199	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000132	0.000198	CbGpPWpGaD
Sucralfate—FGF2—Immune System—C3—amyotrophic lateral sclerosis	0.000129	0.000195	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	0.000128	0.000193	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	0.000126	0.00019	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	0.000125	0.000189	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	0.000125	0.000189	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000124	0.000186	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000123	0.000185	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	0.000121	0.000182	CbGpPWpGaD
Sucralfate—EGF—Disease—PTGS2—amyotrophic lateral sclerosis	0.00012	0.000181	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	0.000119	0.000178	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	0.000119	0.000178	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000118	0.000177	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—SOD1—amyotrophic lateral sclerosis	0.000114	0.000171	CbGpPWpGaD
Sucralfate—FGF2—Disease—APOE—amyotrophic lateral sclerosis	0.000111	0.000167	CbGpPWpGaD
Sucralfate—ALB—Metabolism—PLB1—amyotrophic lateral sclerosis	0.00011	0.000166	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	0.000109	0.000163	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	0.000106	0.00016	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	0.000106	0.00016	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	0.000102	0.000153	CbGpPWpGaD
Sucralfate—ALB—Metabolism—GSR—amyotrophic lateral sclerosis	0.000102	0.000153	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.000102	0.000153	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000101	0.000151	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	9.47e-05	0.000142	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	9.27e-05	0.000139	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	8.77e-05	0.000132	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—C3—amyotrophic lateral sclerosis	8.37e-05	0.000126	CbGpPWpGaD
Sucralfate—ALB—Metabolism—CHAT—amyotrophic lateral sclerosis	8.36e-05	0.000126	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—TP53—amyotrophic lateral sclerosis	8.21e-05	0.000124	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—TP53—amyotrophic lateral sclerosis	8.05e-05	0.000121	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—TP53—amyotrophic lateral sclerosis	8.05e-05	0.000121	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	7.83e-05	0.000118	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	7.79e-05	0.000117	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	7.63e-05	0.000115	CbGpPWpGaD
Sucralfate—FGF2—Disease—PTGS2—amyotrophic lateral sclerosis	7.62e-05	0.000115	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	7.4e-05	0.000111	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—IGF1—amyotrophic lateral sclerosis	6.92e-05	0.000104	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	6.64e-05	9.99e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	6.44e-05	9.68e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	5.23e-05	7.86e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—TP53—amyotrophic lateral sclerosis	5.02e-05	7.55e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.96e-05	7.45e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.68e-05	7.04e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—VEGFA—amyotrophic lateral sclerosis	4.52e-05	6.8e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.49e-05	6.76e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.21e-05	6.33e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.13e-05	6.21e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—TP53—amyotrophic lateral sclerosis	3.42e-05	5.14e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—APOE—amyotrophic lateral sclerosis	3.4e-05	5.11e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.18e-05	4.78e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.33e-05	3.5e-05	CbGpPWpGaD
